Alfred I. duPont Hospital for Children - Nemours Deleware — Wilmington, Delaware

Alfred I. duPont Hospital for Children - Nemours Deleware is a clinical research site located in Wilmington, Delaware, United States 19803.

Crixeo Clinical Trials Trust Score: 95/100 (GOOD). This profile has not yet been claimed by the site owner.

Alfred I. duPont Hospital for Children - Nemours Deleware has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: B-cell Acute Lymphoblastic Leukemia.

Sponsors: Pediatric Transplantation & Cellular Therapy Consortium.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Wilmington

Browse all research sites in Delaware · View every site in Wilmington

Sponsor Feasibility Report

Trust Score: 95/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Alfred I. duPont Hospital for Children - Nemours Deleware?

Alfred I. duPont Hospital for Children - Nemours Deleware has a Crixeo Trust Score of 95/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Alfred I. duPont Hospital for Children - Nemours Deleware conducted?

Alfred I. duPont Hospital for Children - Nemours Deleware has 1 clinical trials on record, with 1 currently active. Their work covers B-cell Acute Lymphoblastic Leukemia.

Is Alfred I. duPont Hospital for Children - Nemours Deleware accredited by Crixeo Clinical Trials?

Alfred I. duPont Hospital for Children - Nemours Deleware has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Alfred I. duPont Hospital for Children - Nemours Deleware?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.